Immunostimulatory activity of recombinant Mycobacterium bovis BCG that secretes major membrane protein II of Mycobacterium leprae

Infection and Immunity

Volumn 74, Issue 11, 2006, Pages 6264-6271

  Makino, Masahiko ^a   Maeda, Yumi ^a   Inagaki, Katsuya ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD4 ANTIGEN; CD8 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CHLOROQUINE; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR MEMBRANE PROTEIN II; MEMBRANE PROTEIN; PERFORIN; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL STRAIN; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INOCULATION; LEPROSY; MEMORY CELL; MONOCYTE; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM LEPRAE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SECRETION; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS;

ANIMALS; BACTERIAL PROTEINS; CELLS, CULTURED; COCULTURE TECHNIQUES; GENETIC ENGINEERING; HUMANS; LEUKOCYTES, MONONUCLEAR; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MYCOBACTERIUM BOVIS; MYCOBACTERIUM LEPRAE; TUBERCULOSIS;

EID: 33750464856     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00878-06     Document Type: Article

References (30)

1. Blander, S. J., L. Szeto, H. A. Shuman, and M. A. Horwitz. 1990. An immunoprotective molecule, the major secretory protein of Legionella pneumophila, is not a virulence factor in a guinea pig model of Legionnaires' disease. J. Clin. Investig. 86:817-824.
2. Bochud, P. Y., T. R. Hawn, and A. Aderem. 2003. Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J. Immunol. 170:3451-3454.
3. Grange, J. M. 1998. Complications of bacille Calmette-Guerin (BCG) vaccination and immunotherapy and their management. Commun. Dis. Public Health 1:84-88.
4. Grode, L., P. Seiler, S. Baumann, J. Hess, V. Brinkmann, A. N. Eddine, P. Mann, C. Goosmann, S. Bandermann, D. Smith, G. J. Bancroft, J.-M. Reyrat, D. van Soolingen, B. Raupach, and S. H. E. Kaufmann. 2005. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin. J. Clin. Investig. 115:2472-2479.
5. Hagge, D. A., N. A. Ray, J. L. Krahenbuhl, and L. B. Adams. 2004. An in vitro model for the lepromatous leprosy granuloma: fate of Mycobacterium leprae from target macrophages after interaction with normal and activated effector macrophages. J. Immunol. 172:7771-7779.
6. Harth, G., B. V. Lee, and M. A. Horwitz. 1997. High-level heterologous expression and secretion in rapidly growing nonpathogenic mycobacteria of four major Mycobacterium tuberculosis extracellular proteins considered to be leading vaccine candidates and drug targets. Infect. Immun. 65:2321-232.
7. Hashimoto, K., Y. Maeda, H. Kimura, K. Suzuki, A. Masuda, M. Matsuoka, and M. Makino. 2002. Mycobacterium leprae infection in monocyte-derived dendritic cells and its influence on antigen-presenting function. Infect. Immun. 70:5167-5176.
8. Horwitz, M. A., G. Harth, B. J. Dillon, and S. Maslesa-Galic. 2000. Recombinant bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc. Natl. Acad. Sci. USA 97:13853-13858.
9. Horwitz, M. A., B. W. Lee, B. J. Dillon, and G. Harth. 1995. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 92:1530-1534.
10. Jiao, X., R. Lo-Man, P. Guermonprez, L. Fiette, E. Deriaud, S. Burgaud, B. Gicquel, N. Winter, and C. Leclerc. 2002. Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity. J. Immunol. 168:1294-1301.
11. Kang, T. J., and G. T. Chae. 2001. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol. Med. Microbiol. 31:53-58.
12. Kaufmann, S. H. E., and A. J. McMichael. 2005. Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat. Med. 11:S33-S44.
13. Krutzik, S. R., B. Tan, H. Li, M. T. Ochoa, P. T. Liu, S. E. Sharfstein, T. G. Graeber, P. A. Sieling, Y.-J. Liu, T. H. Rea, B. R. Bloom, and R. L. Modlin. 2005. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat. Med. 11:653-660.
14. Liu, Y. J. 2001. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106:259-262.
15. Lombardi, C., E. S. Pedrazzani, J. C. Pedrazzani, P. F. Filho, and F. Zicker. 1996. Protective efficacy of BCG against leprosy in San Paulo. Bull. Pan Am. Health Organ. 30:24-30.
16. Maeda, S., M. Matsuoka, N. Nakata, M. Kai, Y. Maeda, K. Hashimoto, H. Kimura, K. Kobayashi, and Y. Kashiwabara. 2001. Multidrug resistant Mycobacterium leprae from patients with leprosy. Antimicrob. Agents Chemother. 45:3635-3639.
17. Maeda, Y., T. Mukai, J. Spencer, and M. Makino. 2005. Identification of immunomodulating agent from Mycobacterium leprae. Infect. Immun. 73:2744-2750.
18. Makino, M., and M. Baba. 1997. A cryopreservation method of human peripheral blood mononuclear cells for efficient production of dendritic cells. Scand. J. Immunol. 45:618-622.
19. Makino, M., Y. Maeda, and N. Ishii. 2005. Immunostimulatory activity of major membrane protein-II from Mycobacterium leprae. Cell. Immunol. 233:53-60.
20. Makino, M., S. Shimokubo, S. Wakamatsu, S. Izumo, and M. Baba. 1999. The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis. J. Virol. 73:4575-4581.
21. Pessolani, M. C., E. R. Smith, B. Rivoire, J. McCormick, S. A. Hefta, S. T. Cole, and P. J. Brennan. 1994. Purification, characterization, gene sequence, and significance of a bacterioferritin from Mycobacterium leprae. J. Exp. Med. 180:319-327.
22. Ponnighaus, J. M., P. E. Fine, J. A. Sterne, R. J. Wilson, E. Msosa, P. J. Gruer, P. A. Jenkins, S. B. Lucas, N. G. Liomba, and L. Bliss. 1992. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi. Lancet 14:636-639.
23. Ridley, D. S., and W. H. Jopling. 1966. Classification of leprosy according to immunity. A five-group system. Int. J. Lepr. Other Mycobact. Dis. 34:255-273.
24. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
25. Sharma, P., R. Mukherjee, G. P. Talwar, K. G. Sarathchandra, R. Walia, S. K. Parida, R. M. Pandey, R. Rani, H. Kar, A. Mukherjee, K. Katoch, S. K. Benara, T. Si, and P. Singh. 2005. Immunoprophylactic effects of the antileprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8-10 years. Lepr. Rev. 76:127-143.
26. Sieling, P. A, D. Jullien, M. Dahlem, T. F. Tedder, T. H. Rea, R. L. Modlin, and S. A. Porcelli. 1999. CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity. J. Immunol. 162:1851-1858.
27. Snapper, S. B., L. Lugosi, A. Jekkel, R. E. Melton, T. Kieser, B. R. Bloom, and W. R. Jacobs, Jr. 1988. Lysogeny and transformation in mycobacteria: stable expression of foreign genes. Proc. Natl. Acad. Sci. USA 85:6987-6991.
28. Wakamatsu, S., M. Makino, C. Tei, and M. Baba. 1999. Monocyte-driven activation-induced apoptotic cell death of human T-lymphotropic virus type I-infected T cells. J. Immunol. 163:3914-3919.
29. Winau, F., S. Weber, S. Sad, J. de Diego, S. L. Hoops, B. Breiden, K. Sandhoff, V. Brinkmann, S. H. E. Kaufmann, and U. E. Schaible. 2006. Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity 24:105-117.
30. World Health Organization. 2003. Leprosy elimination campaigns: impact on case detection. Wkly. Epidemiol. Rec. 78:9-16.